PANVAC™-VF Vaccine for the Treatment of Metastatic Pancreatic Cancer After Failing a Gemcitabine-Containing Regimen
Status unconfirmed · Phase 3
Conditions studied: Pancreatic Cancer
In brief
The objectives of this multi-center, randomized, controlled trial are to evaluate the safety and efficacy of PANVAC-VF in combination with Granulocyte-macrophage colony-stimulating factor (GM-CSF) versus best supportive care or palliative chemotherapy.
Key facts
- Study ID
- NCT00088660
- Run by
- Therion Biologics Corporation
- People needed
- 250
- Starts
- 2004-06-01
- Last updated by the study team
- 2006-02-08
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Patients > 18 years of age who have been vaccinated against smallpox;
- Histologically confirmed diagnosis of adenocarcinoma of the pancreas;
- Patient has metastatic (Stage IV) disease;
- ECOG performance status 0-1;
- Failed a gemcitabine-containing chemotherapeutic regimen within 3 months of study entry.
You may not qualify if…
- Prior or concurrent immunotherapy for cancer;
- Radiation therapy within 28 days prior to registration;
- Systemic corticosteroid therapy (except inhaled or topical steroids) within 28 days of registration;
- Significant cardiovascular abnormalities or diseases;
- Known positive for HIV, hepatitis B and/or C;
- Evidence of immunodeficiency or immune suppression.
Where it is running
- Moores UCSD Cancer Center — La Jolla, California, United States
- Pacific Shores Medical Group — Long Beach, California, United States
- USC/Norris Comprehensive Cancer Center — Los Angeles, California, United States
- Chao Family Comprehensice Cancer Center — Orange, California, United States
- Desert Hematology Oncology Medical Group, Inc — Rancho Mirage, California, United States
- Scripps Cancer Center — San Diego, California, United States
- VA San Diego Healthcare System — San Diego, California, United States
- University of Colorado Health Science Center — Aurora, Colorado, United States
- Greeley Medical Clinic — Greeley, Colorado, United States
- Loveland Hematology Oncology — Loveland, Colorado, United States
- Norwalk Hospital/ Whittingham Cancer Center — Norwalk, Connecticut, United States
- Lombardi Comprehensive Cancer Center — Washington D.C., District of Columbia, United States
- Washington Hospital Cancer Center — Washington D.C., District of Columbia, United States
- Jupiter Medical Center — Jupiter, Florida, United States
- VA Medical Center — Miami, Florida, United States
- Jackson Memorial Hospital — Miami, Florida, United States
- Sylvester Cancer Center — Miami, Florida, United States
- St. Luke's Mountain States Tumor Institute — Boise, Idaho, United States
- North Idaho Cancer Center — Coeur d'Alene, Idaho, United States
- Carle Cancer Center — Urbana, Illinois, United States
- Oncology Associates — Cedar Rapids, Iowa, United States
- University of Kentucky — Lexington, Kentucky, United States
- Hematology Oncology Life Center — Alexandria, Louisiana, United States
- Medical Oncology, LLC — Baton Rouge, Louisiana, United States
- University of South Alabama/ Cancer Research Institute — Mobile, Alabama, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.